The effectiveness of immunotherapeutic strategies against TAMs is limited (83); therefore, considering the significant role of the Hippo-YAP pathway in TAMs, investigators have identified YAP as a potential target for tumor-targeted therapy. This evidence concerns the gene YAP1 and neoplasm.